Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

By Bacci Gaetano   Briccoli Antonio   Longhi Alessandra   Ferrari Stefano   Mercuri Mario   Faggioli Franca   Versari Michela   Picci Piero  

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 748-755

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

By Braud A.C.   Asselain B.   Scholl S.   De La Rochefordiere   Palangie T.   Dieras V.   Pierga J.Y.   Dorval T.   Jouve M.   Beuzeboc P.   Pouillart P.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

By Kudawara Ikuo  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 41-48

Maney Publishing

Access to resources Recommend Favorite

Management of axillary staging in breast cancer patients treated with neoadjuvant chemotherapy

By Sbaity Eman   Cody Hiram S  

Breast Cancer Management, Vol. 2, Iss. 6, 2013-11 ,pp. : 499-505

Future Medicine

Access to resources Recommend Favorite

Omental Chemotherapy Effects as a Prognostic Factor in Ovarian Cancer Patients Treated With Neoadjuvant Chemotherapy and Delayed Primary Surgical Debulking

By Le Tien   Williams Kona   Senterman Mary   Hopkins Laura   Faught Wylam   Fung-Kee-Fung M.  

Annals of Surgical Oncology, Vol. 14, Iss. 9, 2007-09 ,pp. : 2649-2653

Springer Publishing Company

Access to resources Recommend Favorite